1. Home
  2. TLSIW

TLSIW

TriSalus Life Sciences Inc. Warrant

Logo TriSalus Life Sciences Inc. Warrant

Health Care

Medical Specialities

Nasdaq

as 03-13-2024 2:05pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

TriSalus Life Sciences Inc is an oncology company integrating standard-of-care treatments and its investigational immunotherapeutic, SD-101, with disruptive Pressure Enabled Drug Delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. TriSalus is a commercial-stage medical device and Phase I clinical-stage pharmaceutical company.

Founded: N/A Country:
United States
United States
Employees: N/A City: WESTMINSTER
Market Cap: N/A IPO Year: 2021
Target Price: N/A AVG Volume (30 days): N/A
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: N/A Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: